Featured Press Releases

MedaSystems secures additional seed financing to advance its AI-driven workflow platform, expanding access and supporting investigator-initiated studies

MedaSystems secures additional seed financing to advance its AI-driven workflow platform, expanding access and supporting investigator-initiated studies

At AAD 2025, five-year data for BIMZELX® (bimekizumab-bkzx) demonstrated sustained skin clearance and long-term efficacy in moderate-to-severe plaque psoriasis

At AAD 2025, five-year data for BIMZELX® (bimekizumab-bkzx) demonstrated sustained skin clearance and long-term efficacy in moderate-to-severe plaque psoriasis

  • 07 Mar 2025

UCB, a global biopharmaceutical company, announced further long-term data from the Phase 3 trials, and...

Otulfi® (ustekinumab-aauz) by Fresenius Kabi Now FDA-Approved as an Interchangeable Biosimilar

Otulfi® (ustekinumab-aauz) by Fresenius Kabi Now FDA-Approved as an Interchangeable Biosimilar

Inoviv launches MasterKey™, a customizable platform for multiplexed protein assays

Inoviv launches MasterKey™, a customizable platform for multiplexed protein assays

HighField Biopharmaceuticals Files INDs for Two ADCplex™ Immunoliposomes with Distinct Payloads to Address Limitations of Current ADCs

HighField Biopharmaceuticals Files INDs for Two ADCplex™ Immunoliposomes with Distinct Payloads to Address Limitations of Current ADCs

Therapeutics Complement Receives FDA IND Clearance to Advance CTx001 into Opti-GAIN, a Phase I/II Clinical Trial in Geographic Atrophy Secondary to AMD

Therapeutics Complement Receives FDA IND Clearance to Advance CTx001 into Opti-GAIN, a Phase I/II Clinical Trial in Geographic Atrophy Secondary to AMD

Matisse Pharmaceuticals receives INN for M6229, recognizing it as a first-in-class drug, isupartob sodium

Matisse Pharmaceuticals receives INN for M6229, recognizing it as a first-in-class drug, isupartob sodium

  • Matisse Pharmaceuticals
  • 15 Dec 2025
Sapio Sciences Collaborates with the Wellcome Sanger Institute on Transforming Digital Laboratories

Sapio Sciences Collaborates with the Wellcome Sanger Institute on Transforming Digital Laboratories

  • Sapio Sciences
  • 11 Dec 2025
Medra Raises $52 Million in Series A Funding to Build Physical AI Scientists

Medra Raises $52 Million in Series A Funding to Build Physical AI Scientists

  • Medra
  • 11 Dec 2025
Voranigo® (vorasidenib) from Servier has received multiple regional Prix Galien Awards

Voranigo® (vorasidenib) from Servier has received multiple regional Prix Galien Awards

  • Servier
  • 09 Dec 2025
FIZE Medical, in an exclusive deal with Asahi Kasei Medical, has launched the FIZE kUO® System in Japan

FIZE Medical, in an exclusive deal with Asahi Kasei Medical, has launched the FIZE kUO® System in Japan

  • FIZE Medical
  • 09 Dec 2025
GMA with MOVIVA®: Setting New Standards in Endoscopic Bariatric Treatment.

GMA with MOVIVA®: Setting New Standards in Endoscopic Bariatric Treatment.

  • Erbe Elektromedizin GmbH
  • 03 Dec 2025
World Drug Delivery Summit 2025
The Digital Pharma Advances Conference 2026

Most Popular
January   2026
M T W T F S S
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.